Castonguay LA - Search Results

1

Screening and identification of a novel class of TGF-β type 1 receptor kinase inhibitor.

Huynh QK, Wise SJ, Koch KA, Castonguay LA, Reid BG, Pagratis EE, Koditek D, Glascock CB, Pitts KR, Turner BA, Liu X, Hung M, Han B, Pagratis N. Huynh QK, et al. Among authors: castonguay la. J Biomol Screen. 2011 Aug;16(7):724-33. doi: 10.1177/1087057111405846. Epub 2011 Apr 26. J Biomol Screen. 2011. PMID: 21521800

2

ASK1 contributes to fibrosis and dysfunction in models of kidney disease.

Liles JT, Corkey BK, Notte GT, Budas GR, Lansdon EB, Hinojosa-Kirschenbaum F, Badal SS, Lee M, Schultz BE, Wise S, Pendem S, Graupe M, Castonguay L, Koch KA, Wong MH, Papalia GA, French DM, Sullivan T, Huntzicker EG, Ma FY, Nikolic-Paterson DJ, Altuhaifi T, Yang H, Fogo AB, Breckenridge DG. Liles JT, et al. J Clin Invest. 2018 Oct 1;128(10):4485-4500. doi: 10.1172/JCI99768. Epub 2018 Jul 19. J Clin Invest. 2018. PMID: 30024858 Free PMC article.

3

Conformational analysis and receptor docking of N-[(1S,2S)-3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-2-methyl-2-{[5-(trifluoromethyl)pyridin-2-yl]oxy}propanamide (taranabant, MK-0364), a novel, acyclic cannabinoid-1 receptor inverse agonist.

Lin LS, Ha S, Ball RG, Tsou NN, Castonguay LA, Doss GA, Fong TM, Shen CP, Xiao JC, Goulet MT, Hagmann WK. Lin LS, et al. Among authors: castonguay la. J Med Chem. 2008 Apr 10;51(7):2108-14. doi: 10.1021/jm7014974. Epub 2008 Mar 12. J Med Chem. 2008. PMID: 18333607

4

Bioisosteric replacement of anilide with benzoxazole: potent and orally bioavailable antagonists of VLA-4.

Lin LS, Lanza TJ Jr, Castonguay LA, Kamenecka T, McCauley E, Van Riper G, Egger LA, Mumford RA, Tong X, MacCoss M, Schmidt JA, Hagmann WK. Lin LS, et al. Among authors: castonguay la. Bioorg Med Chem Lett. 2004 May 3;14(9):2331-4. doi: 10.1016/j.bmcl.2004.01.098. Bioorg Med Chem Lett. 2004. PMID: 15081035

5

Binding of 2-aryl-4-(piperidin-1-yl)butanamines and 1,3,4-trisubstituted pyrrolidines to human CCR5: a molecular modeling-guided mutagenesis study of the binding pocket.

Castonguay LA, Weng Y, Adolfsen W, Di Salvo J, Kilburn R, Caldwell CG, Daugherty BL, Finke PE, Hale JJ, Lynch CL, Mills SG, MacCoss M, Springer MS, DeMartino JA. Castonguay LA, et al. Biochemistry. 2003 Feb 18;42(6):1544-50. doi: 10.1021/bi026639s. Biochemistry. 2003. PMID: 12578367

6

Prediction of q-values and conformations of gadolinium chelates for magnetic resonance imaging.

Castonguay LA, Treasurywala AM, Caulfield TJ, Jaeger EP, Kellar KE. Castonguay LA, et al. Bioconjug Chem. 1999 Nov-Dec;10(6):958-64. doi: 10.1021/bc990027b. Bioconjug Chem. 1999. PMID: 10563764

7

Novel inhibitors of potassium ion channels on human T lymphocytes.

Michne WF, Guiles JW, Treasurywala AM, Castonguay LA, Weigelt CA, Oconnor B, Volberg WA, Grant AM, Chadwick CC, Krafte DS, et al. Michne WF, et al. Among authors: castonguay la. J Med Chem. 1995 May 26;38(11):1877-83. doi: 10.1021/jm00011a007. J Med Chem. 1995. PMID: 7540207

8

A proposed structural model of domain 1 of fasciclin III neural cell adhesion protein based on an inverse folding algorithm.

Castonguay LA, Bryant SH, Snow PM, Fetrow JS. Castonguay LA, et al. Protein Sci. 1995 Mar;4(3):472-83. doi: 10.1002/pro.5560040314. Protein Sci. 1995. PMID: 7795530 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

8 results

Search Page